1. The biotech resurrection continues — Industry and FDA begin to hammer out PDUFA VII details — JNJ single-shot COVID-19 vaccine shows early promise — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

How CMOs can help reduce your manufacturing risk

Discussion in 'Pharma Contract Manufacturing - General Discussion' started by anonymous, Mar 8, 2012 at 3:57 PM.

Tags: Add Tags
  1. #1 anonymous, Mar 8, 2012 at 3:57 PM
    anonymous

    anonymous Guest

    This new white paper is hosted at Pharmaceutical Technology. Contract manufacturing organizations (CMOs) exist in an environment of continuous improvement and evolving quality standards.

    http://www.pharmtech.com/pharmtech/...cturing/ArticleStandard/Article/detail/758711

    By scientifically affirming every decision and by embracing integral approaches to quality, CMOs can reduce regulatory risk and become a leader in developing best practices meeting current Good Manufacturing Practices (cGMPs).
     
    Quote

Reply to Thread